EURAS Project

EURAS Project

Research Services

Patient Research Partnership – Towards New Treatments for Neurodevelopmental RASopathies

About us

The EURAS project brings together patients and researchers to combine patient-reported data with cutting-edge technologies for the development of effective disease management strategies for neurodevelopmental RASopathies. Patients are at the core of EURAS. Their perspectives inform all project activities. EURAS brings together European patient organisations representing more than 1200 families. Together, they form a transnational network for support, exchange and awareness-raising. By setting up a PATient registry of RASopathies (PATRAS), EURAS will have access to large and, until now, unique datasets from patient cohorts. As data collection on rare diseases is particular challenging, EURAS firmly believes that their foundational work will be of immense benefit for future research on rare diseases. PATRAS allows EURAS researchers to work on the stratification of patient cohorts, assess disease progression and evaluate treatment effectiveness. The project uses stem cell technology to develop novel disease models that will represent disease variability more accurately. Based on these models, researchers investigate disease mechanisms and test the efficacy of newly identified treatments. Furthermore, EURAS partners develop new technologies for drug screening and for non-invasive delivery of therapeutic drugs to the brain. Finally, they will also conduct preclinical proof-of-concept trials with repurposed drugs, antisense oligonucleotides and motor-cognitive training. Funded by the European Union.

Website
www.euras-project.eu
Industry
Research Services
Company size
51-200 employees
Founded
2023

Updates

Affiliated pages

Similar pages